SCHEMBL29566410

SCHEMBL29566410

CC(C)c1ccccc1-c1cc(S(C)(=O)=O)nc(NS(=O)(=O)c2cccc([N+](=O)[O-])c2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ DDX3X O00571 1/20 0.43
▸ NFKBIA P25963 1/20 0.43
▸ RELA Q04206 1/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ EDNRA P25101 2/20 0.42
▸ TYMS P04818 1/20 0.42
▸ PGR P06401 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ MMP1 P03956 1/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ MMP9 P14780 1/20 0.41
▸ MMP8 P22894 1/20 0.41
▸ MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26806638 1.00 LMNA (0.49) LMNAALDH1A1KDM4EMAPTDDX3X
SCHEMBL26806595 0.88 LMNA (0.47) LMNAALDH1A1KDM4EMAPTDDX3X
SCHEMBL24309597 0.87 LMNA (0.54) LMNAALDH1A1KDM4EMAPTDDX3X
SCHEMBL29566518 0.87 LMNA (0.54) LMNAALDH1A1KDM4EMAPTDDX3X
SCHEMBL29566406 0.87 LMNA (0.49) LMNAALDH1A1KDM4EMAPTDDX3X
SCHEMBL26806641 0.87 LMNA (0.49) LMNAALDH1A1KDM4EMAPTDDX3X
SCHEMBL29567669 0.86 LMNA (0.45) LMNAALDH1A1KDM4EMAPTDDX3X
SCHEMBL26806646 0.83 TSHR (0.36) LMNAALDH1A1KDM4EMAPTKMT2A
SCHEMBL24298738 0.81 LMNA (0.56) LMNAALDH1A1KDM4EMAPTDDX3X
SCHEMBL29566361 0.81 LMNA (0.41) LMNAALDH1A1KDM4EMAPTDDX3X

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback